Search

Your search keyword '"Prostate Cancer"' showing total 142,042 results

Search Constraints

Start Over You searched for: Descriptor "Prostate Cancer" Remove constraint Descriptor: "Prostate Cancer" Database OpenAIRE Remove constraint Database: OpenAIRE
142,042 results on '"Prostate Cancer"'

Search Results

1. Predictive Factors for Late Rectal Toxicity in Prostate Cancer Patients after Intensity Modulated Radiation Therapy

2. Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance

3. Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer

4. 実臨床での前立腺癌骨転移症例における骨吸収抑制薬関連顎骨壊死発症関連因子の検討

5. Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers

6. Predicting Erectile Dysfunction after Highly Conformal, Hypofractionated Radiotherapy to the Prostate

7. The association between fatty acids intake and prostate cancer, and the potential for effect modification from organophosphate pesticides among the agricultural health study population

8. Educational differences in healthcare use among survivors after breast, prostate, lung, and colon cancer – a SEQUEL cohort study

9. Transcriptome Analysis Identifies Tumor Immune Microenvironment Signaling Networks Supporting Metastatic Castration-Resistant Prostate Cancer

10. Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance

11. Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease

12. Health Care Costs Attributable to Prostate Cancer in British Columbia, Canada: A Population-Based Cohort Study

13. In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin

14. Strong instrumental variables biased propensity scores in comparative effectiveness research: A case study in oncology

15. Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence

16. Impact of umbilical cord mesenchymal stromal/stem cell secretome and cord blood serum in prostate cancer progression

17. Differential adoption of castration‐resistant prostate cancer treatment across facilities in a national healthcare system

19. Intermediate-risk Prostate Cancer—A Sheep in Wolf’s Clothing?

20. DGN-Handlungsempfehlung (S1-Leitlinie) – PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms – Stand: 01/2022 – AWMF-Registernummer: 031-055

21. PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism?

22. Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria

23. Increasing the value of PSA through improved implementation

24. Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer

25. Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging

26. Management of late events after conventional radical prostate radiotherapy: against the odds of secondary tumours and recurrence of prostate cancer

27. Outcome of Low-Dose-Rate Brachytherapy in Patients with Prostate Cancer and the Characteristics of Patients with Recurrence

28. A Case of Malacoplakia of the Prostate which was Difficult to Distinguish from Prostate Cancer

29. Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer

30. Enhanced Performance Electrochemical Biosensor for Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptamer

31. Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study

32. Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

33. Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging

34. Prostate biopsy and its outcome in a tertiary hospital in southern Nigeria

35. Gestion pratique des inhibiteurs de PARP : Un consensus national DELPHI

36. Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer

37. Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial

38. Evaluation of Patients with Localized Prostate Cancer in whom Long-Term Successful Androgen Deprivation Therapy was Ceased

39. American Society of Anesthesiologists (ASA) physical status system predicts the risk of postoperative Clavien–Dindo complications greater than one at 90 days after robot-assisted radical prostatectomy: final results of a tertiary referral center

40. Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study

41. Discontinuation of denosumab in men with prostate cancer

42. Clinical Analysis of Perioperative Outcomes on Neoadjuvant Hormone Therapy before Laparoscopic and Robot-Assisted Surgery for Localized High-Risk Prostate Cancer in a Chinese Cohort

43. Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec

44. [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients

45. Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers

46. Recommendations for radiation therapy in oligometastatic prostate cancer

47. Predictors of Unfavorable Pathology in Patients with Incidental (pT1a–T1b) Prostate Cancer

48. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study

49. Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer

50. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer

Catalog

Books, media, physical & digital resources